The details about the elimination of the drug from the body by various methods. drug metabolism, drug transformation, drug elimination process. factors affecting.
Introduction
Mechanisms of protein drug binding
Kinetics of protein drug binding
Classes of protein drug binding.
1. Binding of drug to blood components.
(a) Plasma proteins
(b) Blood cells
2. Binding of drug to extravascular tissue protein
Determination of Protein-drug Binding
Factors affecting protein drug binding
Significance of protein/tissue binding of drug
Introduction
Mechanisms of protein drug binding
Kinetics of protein drug binding
Classes of protein drug binding.
1. Binding of drug to blood components.
(a) Plasma proteins
(b) Blood cells
2. Binding of drug to extravascular tissue protein
Determination of Protein-drug Binding
Factors affecting protein drug binding
Significance of protein/tissue binding of drug
Biopharmaceutics: Mechanisms of Drug AbsorptionSURYAKANTVERMA2
Biopharmaceutics is defined as the study of factors influencing the rate and amount of drug that reaches the systemic circulation and the use of this information to optimise the therapeutic efficacy of the drug products.
KINETICS OF MULTIPLE DOSING under the Unit Multicompartment Models According to New PCI syllabus 2017 by Ms. Preeti Patil-Vibhute, Assistant Professor, Sarojini College of Pharmacy, Kolhapur.
Methods of enhancing Dissolution and bioavailability of poorly soluble drugsRam Kanth
Greetings!
Good Day to all...
Topic: Methods of Enhancing Bioavailability
Several approaches discussed are
1. Micrnoization
2. Use of Surrfactants
3. Use of Salt forms
4. Alteration of pH of microenvironment
5. Use of metastable polymorphs
6. Solute-Solvent Complexation
7. Solvent Deposition
8. Selective Adsorption on Insoluble Carriers
9. Solid Solutions
10. Eutectic Mixtures
11. Solid Dispersions
12. Molecular Encapsulation with Cyclodextrins
Please do clarify for doubts if any....
Thank you all for watching this presentation.
Methods for Measurement of bioavailability pharmacampus
Which are the Methods for Measurement of bioavailability?- Pharmacokinetic method- Plasma level time studies, Urinary excretion studies.
Pharmacodynamic method: Acute pharmacologic response, Therapeutic response.
c ADVANCED BIOPHARMACEUTICS AND PHARMACOKINETICS PRESENTATION BY- NARAYAN R K...NarayanRajaramkote
INTRODUCTION
Excretion is defined as the process whereby drugs and/or their metabolites are irreversibly transferred from internal to external environment.
Excretion of unchanged or intact drug is important in the termination of its pharmacological action.
The principal organs of excretion are kidneys. Excretion of drug by kidneys is called as renal excretion.
Excretion by organs other than kidneys such as lungs, biliary system, intestine, salivary glands and sweat glands is known as nonrenal excretion. Almost all drugs and their metabolites are excreted by the kidneys to some extent or the other.
Some drugs such as gentamicin are exclusively eliminated by renal route only.
Agents that are excreted in urine are –
1. Water-soluble.
2. Non-volatile.
3. Small in molecular size (less than 500 Daltons).
4. The ones that are metabolised slowly
The basic functional unit of kidney involved in excretion is the nephron. Each kidney comprises of one million nephrons.
Each nephron is made up of the glomerulus, the proximal tubule, the loop of Henle, the distal tubule and the collecting tubule.
Glomerular Filtration :
Glomerular filtration is a non-selective, unidirectional process whereby most compounds, ionised or unionised, are filtered except those that are bound to plasma proteins or blood cells and thus behave as macromolecules.
The driving force for filtration through the glomerulus is the hydrostatic pressure of the blood flowing in the capillaries. Out of the 25% of cardiac output or 1.2 litres of blood/min that goes to the kidneys via renal artery, only 10% or 120 to 130 ml/min is filtered through the glomeruli, the rate being called as the glomerular filtration rate (GFR).
The GFR can be determined by an agent that is excreted exclusively by filtration and is neither secreted nor reabsorbed in the tubules. The excretion rate value of such an agent is 120 to 130 ml/min. Creatinine, inulin, mannitol and sodium thiosulphate are used to estimate GFR of which the former two are widely used to estimate renal function.
Biopharmaceutics: Mechanisms of Drug AbsorptionSURYAKANTVERMA2
Biopharmaceutics is defined as the study of factors influencing the rate and amount of drug that reaches the systemic circulation and the use of this information to optimise the therapeutic efficacy of the drug products.
KINETICS OF MULTIPLE DOSING under the Unit Multicompartment Models According to New PCI syllabus 2017 by Ms. Preeti Patil-Vibhute, Assistant Professor, Sarojini College of Pharmacy, Kolhapur.
Methods of enhancing Dissolution and bioavailability of poorly soluble drugsRam Kanth
Greetings!
Good Day to all...
Topic: Methods of Enhancing Bioavailability
Several approaches discussed are
1. Micrnoization
2. Use of Surrfactants
3. Use of Salt forms
4. Alteration of pH of microenvironment
5. Use of metastable polymorphs
6. Solute-Solvent Complexation
7. Solvent Deposition
8. Selective Adsorption on Insoluble Carriers
9. Solid Solutions
10. Eutectic Mixtures
11. Solid Dispersions
12. Molecular Encapsulation with Cyclodextrins
Please do clarify for doubts if any....
Thank you all for watching this presentation.
Methods for Measurement of bioavailability pharmacampus
Which are the Methods for Measurement of bioavailability?- Pharmacokinetic method- Plasma level time studies, Urinary excretion studies.
Pharmacodynamic method: Acute pharmacologic response, Therapeutic response.
c ADVANCED BIOPHARMACEUTICS AND PHARMACOKINETICS PRESENTATION BY- NARAYAN R K...NarayanRajaramkote
INTRODUCTION
Excretion is defined as the process whereby drugs and/or their metabolites are irreversibly transferred from internal to external environment.
Excretion of unchanged or intact drug is important in the termination of its pharmacological action.
The principal organs of excretion are kidneys. Excretion of drug by kidneys is called as renal excretion.
Excretion by organs other than kidneys such as lungs, biliary system, intestine, salivary glands and sweat glands is known as nonrenal excretion. Almost all drugs and their metabolites are excreted by the kidneys to some extent or the other.
Some drugs such as gentamicin are exclusively eliminated by renal route only.
Agents that are excreted in urine are –
1. Water-soluble.
2. Non-volatile.
3. Small in molecular size (less than 500 Daltons).
4. The ones that are metabolised slowly
The basic functional unit of kidney involved in excretion is the nephron. Each kidney comprises of one million nephrons.
Each nephron is made up of the glomerulus, the proximal tubule, the loop of Henle, the distal tubule and the collecting tubule.
Glomerular Filtration :
Glomerular filtration is a non-selective, unidirectional process whereby most compounds, ionised or unionised, are filtered except those that are bound to plasma proteins or blood cells and thus behave as macromolecules.
The driving force for filtration through the glomerulus is the hydrostatic pressure of the blood flowing in the capillaries. Out of the 25% of cardiac output or 1.2 litres of blood/min that goes to the kidneys via renal artery, only 10% or 120 to 130 ml/min is filtered through the glomeruli, the rate being called as the glomerular filtration rate (GFR).
The GFR can be determined by an agent that is excreted exclusively by filtration and is neither secreted nor reabsorbed in the tubules. The excretion rate value of such an agent is 120 to 130 ml/min. Creatinine, inulin, mannitol and sodium thiosulphate are used to estimate GFR of which the former two are widely used to estimate renal function.
I am a pharmacist these slides describe detail explanation on clearance and elimination. I hope pharmacy department students get more benefits about it.
Clearance of drugs.
Elimination of drugs - sites
Review of renal physiology.
Nature of drugs & factors affecting elimination.
Drug half life
Steady state concentration & Maintenance dose.
Clearance: Volume of plasma that is cleared of drug per unit time.
Elimination rate: is mass/amount of drug that is cleared from the body.
Clearance is related with elimination by a constant proportion factor.
Stability testing protocol for herbal products in a detailed review.It’s the ability of formulation to retain its physical, chemical, microbiological and toxicological parameter same as that time of manufacture .
Drug product remains within specifications established to ensure its identity, strength, quality and purity.
Stability – Chemical and Physical integrity of herbal medicinal products.
Over a given time period and under the influence of environmental factors including temperature, humidity and light.
To provide evidence on how the quality of active substance varies with time and environmental factors
To establish re- test period for active substance
To establish shelf life of finished products.
To recommend storage conditions.
To evaluate the efficacy of drug.
To develop suitable packing information for drug product
To submit stability information for regulatory agencies.
1.Physical stability study:-
The original physical properties namely appearance, uniformity, palatability, dissolution, and suspend ability are maintained.
Chemical stability study:-
Each and every active ingredient retains its chemical integrity as well as potency specified on label, within the specified limits.
It involves drug assay and determination of drug degradation.
FAIRNESS CREAM FORMULATIONS
PHARMACOGNOSY DATA FOR HERBAL COSMETICS, IT CONSISTS OF THE DATA ABOUT THE SKIN AND THE FORMULATION OF THE FAIRNESS CREAMS AND THEIR EVALUATION AND EFFECTS
DRUGS USED IN THE TREATMENT OF BRONCHIAL ASTHMA AND COPD
Characterized by hyper responsiveness of bronchial smooth muscle to a variety of stimuli”
Resulting in:
Narrowing of air ways
Increased secretion
Mucosal edema
Mucus plugging
Cholera is a acute diarrhoeal disease caused by Vibrio cholerae.
Majority of infection are mild or asymptomatic.
IV B.PHARM, 8-SEMESTER ,SOCIAL AND PREVENTIVE PHARMACY.
CHOLERA DISESASE
DEFINITION, SYMPTOMS, CAUSES, TREATMENT, PREVENTION.
More from NEW ROYAL CARE PHARMACY, SALEM, TAMILNADU, INDIA - 636011 (6)
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
2. DRUG ELIMINATION:
❖ Drugs are removed from the body by various elimination
processes.
❖ It is defined as the irreversible loss of drug from the
body.
❖ It occurs by two processes:
METABOLISM EXCRETION
ELIMINATION = METABOLISM + EXCRETIONN
5. METABOLISM OF DRUGS:
❖ It is also called as BIOTRANSFORMATION
❖ It is defined as the biochemical modification of a drug in the body.
❖ Once drug enters the body it undergoes ABSORPTION,
DISTRIBUTION,METABOLISM, ELIMINATION.
❖ METABOLISM is an important process which reduces the toxicity of
the Drug in the body.
Protein soluble ------> water soluble
8. METABOLIC PATHWAYS:
It is divided into two phases,
METABOLISM
PHASE I PHASE II
★ OXIDATION
★ REDUCTION
★ HYDROLYSIS
★ SULPHONATION
★ ACETYLATION
★ METHYLATION
★ GLUTATHIONE
CONJUGATION
★ GLUCURONIDATION
9.
10. PHASE I METABOLISM:
❖ A molecule of drug initially enters into the PHASE I METABOLISM
❖ It undergoes sequence of reactions
❖ Attachment of functional groups to the drugs like -OH,-SH,-NH2
❖ It helps in the CONJUGATION of drug in PHASE II easily.
❖ Converts itself into forms that shows reduced solubility in lipids as well
as in water so that it's excretion is facilitated.
REACTIONS:
★ OXIDATION
★ REDUCTION
★ HYDROLYSIS
11. OXIDATION:
❖ Liver cells are the most common site for OXIDATION.
❖ Oxidation involves conversion of a C-H bond to a C-OH.
❖ This reaction sometimes converts a pharmacologically inactive
compound (a prodrug) to a pharmacologically active one.
❖ By the same token, Phase I can turn a nontoxic molecule into a
poisonous one (toxification).
RH + O2 + NADPH + H+ --------> ROH + H2O + NADP+
12.
13. REDUCTION:
❖ Drugs containing an aldehyde,ketone , disulphide,quinine,N- oxide
,alkene ,azo or Nitro group undergo In Vivo reduction.
❖ Alcohol dehydrogenation < ------ > carbonyl reduction
❖ N- Oxidation < ------- > Amine oxide reduction
Eg:
14. HYDROLYSIS:
❖ Cleavage of drug molecule by taking up a molecule of water.
SITES :
★ Liver
★ Intestines
★ Plasma
★ Other tissues
Eg.
15. PHASE II METABOLISM:
❖ In PHASE II reactions,drugs are combined with hydrophilic
endogenous compound to form complex which allows rapids excretion.
❖ It is also called as CONJUGATION REACTIONS.
❖ PHASE II reactions are much faster than PHASE I reactions.
★ SULPHONATION
★ ACETYLATION
★ METHYLATION
★ GLUTATHIONE
CONJUGATION
★ GLUCURONIDATION
16. Glucuronidation -OH,-COOH,-NH2, ,-SH,-CH,-NH
Sulphonation Aromatic-OH,Aromatic -NH2,alcohols
Acetylation Hydrazine,-SO2,,-NH2
Methylation Aromatic -OH ,-NH2 ,-NH,-SH
Glutathione
conjunction
Epoxides and organic halides
Glycine conjunction Aromatic-NH2, and -COOH
CONJUGATION REACTIONS & FUNCTIONAL GROUPS
17. GLUCURONIDATION:
❖ GLUCURONIDATION is quantitatively the most significant PHASE II
reaction.
❖ Glucuronic acid conjunction occurs only when glucuronic acid gets
activated.
Eg: O - Glucuronides
18. FACTORS AFFECTING DRUG METABOLISM:
❖ Biological factor's
➢ Age
➢ Diet
➢ Sex
➢ Weight
➢ Others
➢ Body temperature
❖ Chemical factor's
➢ Enzyme inhibitors
➢ Enzyme stimulators
❖ Physico chemical properties of drug
20. EXCRETION:
❖ EXCRETION remove the drugs or their metabolites from the body.
❖ KIDNEYS are the principal organs for excretion.
❖ The other organs include lungs,biliary system, intestines,salivary
gland, sweat glands.
❖ All lipid soluble drugs are converted into water soluble compounds by
the metabolic process which favours the excretion process.
21. CLEARANCE:
DEFINITION:
❖ It is defined as the complete removal of a drug in a specified time
period from the hypothetical volume of body fluids containing the
drug.
UNIT:. ml/min
It describes the relationship between plasma drug concentration and the
rate of drug elimination.
Elimination rate
Clearance(cl)= ----------------------------------
Plasma drug concentration
22. RENAL CLEARANCE:
❖ The clearance takes place in kidney are called as RENAL CLEARANCE.
❖ Blood volume or plasma volume, completely cleared of the drug in its
unchanged from , by the kidneys per unit time.
❖ Clearance is a measure of renal function.
Rate of urinary excretion
ClR = -----------------------------------
Plasma drug concentration
Rate of filtration+rate of secretion - rate of reabsorption
ClR = -----------------------------------------------------------------------------
C
23. EXCRETION OF DRUGS
Renal Excretion of Drugs Non - Renal Excretion of Drug
★ The excretion of drugs by the
KIDNEYS.
★ Eg: drugs like gentamicin
★ In this excretion, drugs are
removed via Urine.
★ The excretion of drugs by all
other routes except the Renal
route( kidney).
★ It involves
○ Biliary excretion
○ Pulmonary excretion
○ Salivary excretion
○ Mammary excretion
○ Skin excretion
○ Gastrointestinal excretion
25. RENAL EXCRETION:
❖ Kidneys are responsible for the excretion of nearly all drugs as well as
their metabolites.
❖ Water soluble, non volatile, small molecule size (<500 Dalton's) are
undergo excretion via Urine.
❖ NEPHRON is the basic functional unit of kidney. One million Nephrons
are present in each kidney.
Rate of Rate of Rate of Rate of
Excretion = Filtration + Secretion - Reabsorption
28. GLOMERULAR FILTRATION:
❖ Most compounds are filtered except that are bound
to plasma protein's
❖ Non - selective process
❖ Occurs in only one direction
❖ Glomerulus behaves as negatively charged
❖ Hydrostatic pressure of blood flowing in the
capillaries acts as driving force for filtration.
❖ Only 10% of cardiac output is filtered through
glomeruli.
29. ❖ The rate of filtration is known as GLOMERULAR
FILTRATION RATE (GFR)
❖ Compounds with 20Å to 42Å may undergo Glomerular
filtration.
❖ Substance used for determination of GFR:
➢ Creatinine
➢ Inulin
➢ Mannitol
➢ Sodium thiosulphate
30. ACTIVE TUBULAR SECRETION:
❖ It is a carrier mediated process.
❖ Compounds are transported in a opposite direction to
the concentration gradient by utilising energy.
TWO SECRETION MECHANISM
1.System for secretion of organic acids/ anions
Eg. penicillin, Salicylate, etc…
2.System for organic base / cations
Eg. Morphine, mecamylamine, hexamethonium .
31. TUBULAR REABSORPTION:
❖ Site - takes place all along Renal tubules.
❖ Results in increases in half life of a drugs.
TWO TYPES:
❖ Active tubular reabsorption:
➢ High threshold endogenous substance or nutrients
which the body needs to preserve.
➢ Eg. Glucose , electrolytes,vitamins, amino acids,uric
acids.
➢ Drugs - oxopurinol
32. ❖ Passive tubular reabsorption
➢ For exogenous substance like drugs.
➢ Concentration gradient takes place - driving force
➢ Lipophilic substance are extensively reabsorbed and
polar not reabsorbed.
REABSORPTION DEPENDS UPON:
● pH of Urine(4.5-7.5)
● Urine flow rate
● pKa of drug
33. FACTORS AFFECTING RENAL EXCRETION:
❖ Physico chemical properties
❖ Drug interactions
❖ Distribution and binding of drug
❖ Blood flow to kidney
❖ Urine pH
❖ Disease state
❖ Biological factor's
❖ Plasma concentrations
34. 1. Physico chemical properties
a. Molecular size
i. Size <300 Dalton's
ii. Excretion of drugs with larger molecular weight is difficult
compared to that of drugs with smaller weights.
b. Lipid solubility
i. Inversely proportional to the urinary excretion
c. Volume of distribution
i. Inversely proportional to the clearance
ii. Lage Vd - poor Excretion in Urine
iii. Small Vd - high excretion in Urine
35. 2. Plasma concentrations of drug
● Glomerular filtration and reabsorption are directly affected by
plasma concentrations
3.Biological factor's
● Renal Excretion is 10% lower in females.
● New born : 30-40% less
● Old age : excretion decreased, increased t1/2.
37. BILIARY EXCRETION OF DRUGS / ENTEROHEPATIC CYCLING
❖ Production and secretion of bile is active proces.
❖ Bile secreted in the liver , stored in gall bladder and released in the
duodenum.
❖ Bile significantly helps in digestion and absorption of fats.
❖ Secretion of bile is a capacity limited process and gets saturated.
Drug concentration in bile (less)
Drug concentration in plasma (higher)
Biliary clearance is low.
Vice-versa…..
38. Based on their bile / plasma concentrations ratio's, the compounds
excreted in bile can be grouped.
GROUPS Bile / plasma
concentrations
Example
GROUP A About 1 Sodium,potassium,chl
oride,glucose
GROUP B More than 1 Bile salts, creatinine,
bilirubin Glucuronides.
GROUP C Less than 1 Sucrose, inulin,
phosphate,
phospholipid.
39. ENTERO HEPATIC CIRCULATION OR CYCLING:
❖ The phenomenon of drug circulation between the intestines and the
liver is called ENTEROHEPATIC CYCLING or CIRCULATION.
❖ Half life - t1/2 - INCREASED
for drugs.
❖ Prolongation of drug action
❖ Eg. Cardiac glycosides ,
rifampicin,
chlorpromazine,
indomethacin.
40.
41. PULMONARY EXCRETION OF DRUGS:
❖ Gaseous and volatile substance such as general anaesthetics
(Halothane) are absorbed through lungs by simple diffusion.
❖ Pulmonary blood flow ,rate of respirations and solubility of substance
affect the pulmonary excretion.
❖ Alcohol which has high solubility in blood and tissues are excreted
slowly by lungs.
Eg: General anaesthetics - Halothane,
nitrous oxide
Alcohol - excreted slowly through
lungs
42. SALIVARY EXCRETION OF DRUGS
❖ It involves Excretion of drugs through saliva by the process of passive
diffusion.
❖ The pH of Saliva varies from 5.8 to 8.4
❖ Unionised lipid soluble drug's are excreted passively
❖ The bitter taste is due to drug excreted
43. ❖ For weak acid ratio's found to be <1
❖ For weak base ratio's found to be >1
❖ Eg . Sulphonamides , antibiotics, clonidine ,etc...
44. MAMMARY EXCRETION OF DRUGS:
❖ A drug that is excreted in milk can enter in infants feeding.
❖ pH of milk ranges from 6.4-7.6 and a mean pH of 7.0
❖ Un ionised , lipid soluble drugs show Passive diffusion in the alveolar
cells of the mammary gland.
❖ The excretion of drugs in milk is usually less than 1%.
❖ Milk bears an acidic nature as compared to plasma.
❖ Drugs are weak basic in nature show greater concentration in milk.
Eg. Chloramphenicol , diazepam , tetracyclines, etc...
45. DRUG EXCRETION IN MILK DEPENDS ON
★ pH partition behaviour
★ Molecular weight
★ Lipid solubility
★ Degree of ionisation
EFFECTS
★ Some potent drugs may induce toxicity in infants.i.e
barbiturates,morphine , ergotamine.
★ Whenever possible, feeding mothers should avoid drugs .
★ If medication is unavoidable, the infant should be bottle fed.
46. SKIN EXCRETION OF DRUGS
❖ It depends on pH partition hypothesis
❖ Passively excreted through skin
❖ Sweat : urea derivatives, amines , heavy metals.
Eg : benzoic acid, Salicylic acid,
alcohol.
47. GASTROINTESTINAL EXCRETION OF DRUGS
❖ GI excretion takes place when drug administered through parenteral
route.
❖ It undergoes passive diffusion
❖ GIT also shows the absorption and excretion of drugs that are
administered orally.
❖ Stomach is the specific site that shows the excretion of water soluble
and ionised forms of drugs that either weak acid or base.
Eg. Nicotine, quinine, magnesium sulphate, streptomycin neomycin,
cholestyramine etc...